Carroll BT, Kathol RG, Noyes Jr R et al. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 1993; 15: 69–74.
de Leeuw JR, de Graeff A, Ros WJ et al. Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck 2000; 22: 799–807.
Bodurka-Bevers D, Basen-Engquist K, Carmack CL et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 2000; 78 (Part 1): 302–308.
Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000; 18: 893–903.
Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001; 84: 1011–1015.
Zabora J, BrintzenhofeSzoc K, Curbow B et al. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10: 19–28.
Holland JC. NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. Oncology (Huntington) 1999; 13: 113–147.
Worden JW, Weisman AD. Do cancer patients really want counseling? Gen Hosp Psychiatry 1980; 2: 100–103.
Sollner W, Zingg-Schir M, Rumpold G et al. Need for supportive counselling – the professionals' vs the patients' perspective. A survey in a representative sample of 236 melanoma patients. Psychother Psychosom 1998; 67: 94–104.
Passik SD, Dugan W, McDonald MV et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998; 16: 1594–1600.
Berard RM, Boermeester F, Viljoen G. Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 1998; 7: 112–120.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737–1744.
Maguire P. Improving communication with cancer patients. Eur J Cancer 1999; 35: 1415–1422.
Rost K, Nutting P, Smith J et al. The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med 2000; 9: 150–154.
Sollner W, DeVries A, Steixner E et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001; 84: 179–185.
Eakin EG, Strycker LA. Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer: patient and provider perspectives. Psychooncology 2001; 10: 103–113.
Ford S, Fallowfield L, Lewis S. Doctor–patient interactions in oncology. Soc Sci Med 1996; 42: 1511–1519.
Smith RC, Lay CD. State and trait anxiety: an annotated bibliography. Psychol Rep 1974; 34: 519–594.
Beck AT, Ward CH, Mendelson M et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 553–571.
Beck AT, Steer RA. Beck depression inventory manual. Antonio, TX: The Psychological Corporation, Harcourt Brace Jovanovich, 1993.
Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991; 32: 705–714.
Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997; 4: 92–100.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
Herrmann C. International experiences with the Hospital Anxiety and Depression Scale – a review of validation data and clinical results. J Psychosom Res 1997; 42: 17–41.
Spinhoven P, Ormel J, Sloekers PP et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363–370.
Hjermstad MJ, Loge JH, Evensen SA et al. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24: 1219–1228.
Dobscha SK, Gerrity MS, Ward MF. Effectiveness of an intervention to improve primary care provider recognition of depression. Eff Clin Pract 2001; 4: 163–171.
Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12: 439–445.
Smith MY, Redd WH, Peyser C, Vogl D. Post-traumatic stress disorder in cancer: a review. Psychooncology 1999; 8: 521–537.
Smith MY, Redd W, DuHamel K et al. Validation of the PTSD Checklist-Civilian Version in survivors of bone marrow transplantation. J Trauma Stress 1999; 12: 485–499.
Andrykowski MA, Cordova MJ, McGrath PC et al. Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psychooncology 2000; 9: 69–78.
Widows MR, Jacobsen PB, Fields KK. Relation of psychological vulnerability factors to posttraumatic stress disorder symptomatology in bone marrow transplant recipients. Psychosom Med 2000; 62: 873–882.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: A Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.
Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Version 4, Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, IL, 1997.
McQuellon RP, Russell GB, Rambo TD et al. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant 1998; 21: 477–486.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74.
Loberiza FR, Rizzo JD, Bredeson CN et al. Association of depressive syndrome and early deaths after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20: 2118–2126.
Horwitz RI, Viscoli CM, Berkman L et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542–545.
McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 1997; 157: 1921–1929.
Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66: 1718–1726.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–2107.
Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888–891.
Fawzy FI, Cousins N, Fawzy NW et al. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990; 47: 720–725.
Reifler DR, Kessler HS, Bernhard EJ et al. Impact of screening for mental health concerns on health service utilization and functional status in primary care patients. Arch Intern Med 1996; 156: 2593–2599.
Williams Jr JW, Mulrow CD, Kroenke K et al. Case-finding for depression in primary care: a randomized trial. Am J Med 1999; 106: 36–43.
Rost K, Nutting P, Smith J et al. Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming. J Gen Intern Med 2001; 16: 143–149.
Kroenke K, Taylor-Vaisey A, Dietrich AJ, Oxman TE. Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature. Psychosomatics 2000; 41: 39–52.
Thompson C, Kinmonth AL, Stevens L et al. Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet 2000; 355: 185–191.
McLachlan SA, Allenby A, Matthews J et al. Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J Clin Oncol 2001; 19: 4117–4125.
Goodwin PJ, Leszcz M, Ennis M et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001; 345: 1719–1726.
Friedman M, Thoresen CE, Gill JJ et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 1986; 112: 653–665.
Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ 1996; 313: 1517–1521.
Berkman LF, Blumenthal J, Burg M et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial (comment). JAMA 2003; 289: 3106–3116.